Scientific Whistleblowers Stress That The Media Are A Last Resort

A Last Resort Those alleging misconduct agree with administrators that the optimal way to settle cases is through institutions, not the press. (The Scientist, Vol:10, #6, p. 1 & 4, March 18, 1996) Scientists do not agree on what misconduct is. They do not agree on how much of it occurs. Nor do they agree on what should be done about it. Yet scientists and research administrators largely do concur that it would be better for all concerned-and for science itself-if the press never got involved i

Written byBilly Goodman
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

A Last Resort Those alleging misconduct agree with administrators that the optimal way to settle cases is through institutions, not the press.

(The Scientist, Vol:10, #6, p. 1 & 4, March 18, 1996)

Scientists do not agree on what misconduct is. They do not agree on how much of it occurs. Nor do they agree on what should be done about it. Yet scientists and research administrators largely do concur that it would be better for all concerned-and for science itself-if the press never got involved in allegations of misconduct except to report final outcomes.

Indeed, the Commission on Research Integrity (CRI)-a 12-member panel created by Congress in reaction to continuing misconduct in research and retaliation against whistleblowers-omitted direct mention of the role of the press in its recently completed report (B. Goodman, The Scientist, Jan. 22, 1996, page 1). Indirectly, panelists had the press at least partly in mind ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies